<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221126056618N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-14</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of biofeedback therapy on MR defecography indicators</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of biofeedback therapy compared to standard treatment on MR defecography indicators in patients with obstructive excretory syndrome.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>28</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67077</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: At first, 4 blocks of 4 were prepared in Excel software as (AA, BB), (BB, AA), (AB, BA), (BA, AB), (AB, AB), (BA, BA) and Then these blocks will be sorted from one to four. A was for the treatment or intervention group and B was for the control group. Then one of these blocks will be randomly selected and based on the sequence of letters A and B in the selected block, the eligible people will be assigned to treatment or control groups, Blinding description: This study is double-blind, so that the evaluator and the subject are not aware of the status of assigning people to the study groups. For the study subjects, before the random assignment, it is explained how the work process is.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Obstructive Defecation syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: It will include people who will be given standard treatment including high-fiber diet, training on bowel movement and laxative use along with biofeedback. Before doing biofeedback, it is necessary for the patient to have full knowledge of the functioning mechanism of the human body and know anorectal anatomy. The examination of the rectal bag is performed on the patient so that the patient gets familiar with the concept of contraction and expansion of the anal sphincter. The training method is side lying, which means that the patient is shown how the anal sphincter works with a bile duct pressure measurement catheter that enters the anal-rectum canal.  With the doctor's explanation and guidance, the patient will be able to distinguish abnormal from normal images in this test and can perform the necessary procedures to increase intra-abdominal pressure and systolic pressure at the same time as the anal sphincter relaxes and repeat. The treatment protocol consists of 3 sessions per week and each session lasts for an hour, and each course consists of 8 sessions and will be accompanied by sessions to strengthen autonomous function at home. Intervention 2: Control group: The patients with diagnosis of Obstructive Defecation Syndrome(ODS) in Imam Khomeini Hospital who are waiting for biofeedback therapy and only receive standard constipation treatment including high fiber diet and using laxatives. These patients undergo MR defecography before and after standard treatment protocol.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data file of the participants, the study protocol, the informed consent form and the clinical study report will be provided to the interested researchers in compliance with the ethical standards, including non-identification of the patients and other such matters.

When:
The data access period will start after the publication of the research articles

To whom:
All researchers interested in working in this field

Conditions:
The data of the study will be made available to interested parties for the purpose of secondary analysis or other relevant research purposes while maintaining the confidentiality of the participants.

Where to obtain:
To receive data, applicants can write to the email address hadavidorsa@gmail.com

How to obtain:
After the correspondence by the applicants in order to receive the data of the study, after the necessary checks, the data will be provided to them within a week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dorsa Hadavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Khomeini Hospital Complex, Dr. Gharib Street, at the end of Keshavarz Boulevard</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۱۹۷۳۳۱۴۱</zip>
        <telephone>0098 21 61190</telephone>
        <email>hadavidorsa@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dorsa Hadavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Khomeini Hospital Complex, Dr. Gharib Street, at the end of Keshavarz Boulevard</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۱۹۷۳۳۱۴۱</zip>
        <telephone>0098 21 61190</telephone>
        <email>hadavidorsa@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Suffering from chronic constipation based on history, clinical examinations and colon transit test and confirming the diagnosis of Obstructive Excretion Syndrome (ODS)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Psychiatric disorders
pregnancy
breastfeeding
Substance abuse</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K59.02</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Outlet dysfunction constipation</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: It will include people who will be given standard treatment including high-fiber diet, training on bowel movement and laxative use along with biofeedback. Before doing biofeedback, it is necessary for the patient to have full knowledge of the functioning mechanism of the human body and know anorectal anatomy. The examination of the rectal bag is performed on the patient so that the patient gets familiar with the concept of contraction and expansion of the anal sphincter. The training method is side lying, which means that the patient is shown how the anal sphincter works with a bile duct pressure measurement catheter that enters the anal-rectum canal.  With the doctor's explanation and guidance, the patient will be able to distinguish abnormal from normal images in this test and can perform the necessary procedures to increase intra-abdominal pressure and systolic pressure at the same time as the anal sphincter relaxes and repeat. The treatment protocol consists of 3 sessions per week and each session lasts for an hour, and each course consists of 8 sessions and will be accompanied by sessions to strengthen autonomous function at home.</i_keyword>
      <i_keyword>Control group: The patients with diagnosis of Obstructive Defecation Syndrome(ODS) in Imam Khomeini Hospital who are waiting for biofeedback therapy and only receive standard constipation treatment including high fiber diet and using laxatives. These patients undergo MR defecography before and after standard treatment protocol.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>MR defecography indicators in patients with obstructive syndrome. Timepoint: The examination of MR defecography indicators  will be at the end of the  third week after entering the study. Method of measurement: Measurement and comparison of the results of the intervention will be done using MRI.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-11-15</approval_date>
        <contact_name>Research Ethics Committee of Imam Khomeini Hospital Complex - Tehran University of Medical Sciences</contact_name>
        <contact_address>Imam Khomeini Hospital Complex, Dr. Gharib Street, at the end of Keshavarz Boulevard, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
